Design and synthesis of 2-(3-alkylaminophenyl)-6-(pyrrolidin-1-yl)quinolin-4-ones as potent antitumor agents. 2013

Shih-Ming Huang, and Yung-Yi Cheng, and Ming-Hua Chen, and Chi-Hung Huang, and Li-Jiau Huang, and Mei-Hua Hsu, and Sheng-Chu Kuo, and Kuo-Hsiung Lee
Graduate Institute of Pharmaceutical Chemistry, China Medical University, Taichung 404, Taiwan.

2-(3-Alkylaminophenyl)-6-(pyrrolidin-1-yl)quinolin-4-ones 1-3 were synthesized and screened for anti-proliferative activity against three human cancer cell lines, as well as the normal cell line Detroit 551. All of the synthesized target compounds 1-3 demonstrated potent cytotoxic activity against the cancer cell lines, but weak inhibitory activity toward the normal cell line. 2-(3-Methyl aminophenyl)-6-(pyrrolidin-1-yl)quinolin-4-one (1), one of the potent compounds in vitro, was also tested in an in vivo Hep3B xenograft nude mice model, and its significant anticancer activity was reconfirmed. Therefore, compound 1 merits further investigation as an antitumor clinical trial candidate and potential anticancer agent.

UI MeSH Term Description Entries
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000814 Aniline Compounds Compounds that include the aminobenzene structure. Phenylamine,Phenylamines,Anilines,Compounds, Aniline
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Shih-Ming Huang, and Yung-Yi Cheng, and Ming-Hua Chen, and Chi-Hung Huang, and Li-Jiau Huang, and Mei-Hua Hsu, and Sheng-Chu Kuo, and Kuo-Hsiung Lee
September 2012, Bioorganic & medicinal chemistry letters,
Shih-Ming Huang, and Yung-Yi Cheng, and Ming-Hua Chen, and Chi-Hung Huang, and Li-Jiau Huang, and Mei-Hua Hsu, and Sheng-Chu Kuo, and Kuo-Hsiung Lee
August 2014, Journal of enzyme inhibition and medicinal chemistry,
Shih-Ming Huang, and Yung-Yi Cheng, and Ming-Hua Chen, and Chi-Hung Huang, and Li-Jiau Huang, and Mei-Hua Hsu, and Sheng-Chu Kuo, and Kuo-Hsiung Lee
January 2023, Chemicke zvesti,
Shih-Ming Huang, and Yung-Yi Cheng, and Ming-Hua Chen, and Chi-Hung Huang, and Li-Jiau Huang, and Mei-Hua Hsu, and Sheng-Chu Kuo, and Kuo-Hsiung Lee
January 2005, Journal of medicinal chemistry,
Shih-Ming Huang, and Yung-Yi Cheng, and Ming-Hua Chen, and Chi-Hung Huang, and Li-Jiau Huang, and Mei-Hua Hsu, and Sheng-Chu Kuo, and Kuo-Hsiung Lee
June 2010, Acta crystallographica. Section E, Structure reports online,
Shih-Ming Huang, and Yung-Yi Cheng, and Ming-Hua Chen, and Chi-Hung Huang, and Li-Jiau Huang, and Mei-Hua Hsu, and Sheng-Chu Kuo, and Kuo-Hsiung Lee
March 2014, European journal of medicinal chemistry,
Shih-Ming Huang, and Yung-Yi Cheng, and Ming-Hua Chen, and Chi-Hung Huang, and Li-Jiau Huang, and Mei-Hua Hsu, and Sheng-Chu Kuo, and Kuo-Hsiung Lee
September 2018, European journal of medicinal chemistry,
Shih-Ming Huang, and Yung-Yi Cheng, and Ming-Hua Chen, and Chi-Hung Huang, and Li-Jiau Huang, and Mei-Hua Hsu, and Sheng-Chu Kuo, and Kuo-Hsiung Lee
June 2010, Bioorganic & medicinal chemistry letters,
Shih-Ming Huang, and Yung-Yi Cheng, and Ming-Hua Chen, and Chi-Hung Huang, and Li-Jiau Huang, and Mei-Hua Hsu, and Sheng-Chu Kuo, and Kuo-Hsiung Lee
January 2022, Anti-cancer agents in medicinal chemistry,
Shih-Ming Huang, and Yung-Yi Cheng, and Ming-Hua Chen, and Chi-Hung Huang, and Li-Jiau Huang, and Mei-Hua Hsu, and Sheng-Chu Kuo, and Kuo-Hsiung Lee
December 2011, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!